Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial

Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:54:05.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study comparing the safety and efficacy of Upadacitinib to Dupilumab in adults with moderate to severe atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T15:59:46.000Z thumbnail image
  7. Check
    26 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the eligibility criteria for participants in a clinical study on atopic dermatitis, specifying the required severity levels and other conditions for inclusion and exclusion. This change is important for individuals monitoring the study for potential participation.
    Difference
    9%
    Check dated 2024-05-21T19:03:59.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:35:00.000Z thumbnail image

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.